🧪 KPV Peptide (10mg Vial)
Research Purity: ≥99% | For Laboratory Use Only

⚡ Product Overview

KPV (Lys-Pro-Val) is a naturally occurring tripeptide fragment derived from α-MSH (alpha-melanocyte-stimulating hormone).
It is widely studied in inflammatory signaling pathways, particularly for its interaction with melanocortin receptors and its role in regulating immune and epithelial responses.

KPV has attracted interest in gut, skin, and immune research models due to its ability to modulate inflammatory cascades without melanogenic activity.

🌟 Key Benefits (Research-Based)

🧬 Anti-Inflammatory Signaling — Studied for downregulation of pro-inflammatory cytokines (TNF-α, IL-6, NF-κB).

🛡️ Barrier Integrity Support — Investigated for maintaining epithelial and mucosal barrier function in gut and skin models.

⚖️ Immune Modulation — May assist in balancing innate immune responses without broad immune suppression.

🧫 Melanocortin Pathway Activity — Acts independently of pigmentation pathways while retaining anti-inflammatory signaling.

🔬 Cellular Protection Potential — Linked to reduced oxidative and inflammatory stress at the cellular level.

KPV is frequently studied alongside complementary peptides to explore broader anti-inflammatory, regenerative, and barrier-support pathways in research models:

🧪 KPV + BPC-157
— Investigated for combined effects on gut lining integrity, inflammatory signaling reduction, and tissue repair pathways.

🧬 KPV + TB-500 (Thymosin Beta-4 Fragment)
— Studied for synergistic modulation of inflammation and cellular migration in soft tissue and recovery models.

🛡️ KPV + GHK-Cu
— Explored in skin and epithelial research for anti-inflammatory signaling, cellular protection, and extracellular matrix support.

⚙️ KPV + MOTS-c
— Researched for combined immune-modulating and mitochondrial signaling effects, particularly in metabolic stress models.

🔬 KPV + SLU-PP-332
— Examined in experimental frameworks focusing on inflammation control alongside metabolic and oxidative stress pathways.

📌 Stacking is conducted strictly in controlled laboratory settings to evaluate complementary signaling pathways and is not indicative of combined use outside of research.